Back to search
FDAFDA · Food and drugs·Recall number D-0323-2024

Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03

Published February 7, 2024 · Recall initiated: January 4, 2024

Summary

FDA records drug Class I recall D-0323-2024, published February 7, 2024 and initiated January 4, 2024. Recalling firm: Azurity Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 4,662 bottles; Lot: Lot # F230169A, Exp. 06/30/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix-up

What to do

Voluntary: Firm initiated · Letter

Get an email if ZENZEDI has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ZENZEDI
Manufacturer
Azurity Pharmaceuticals, Inc.
Distributor
USA nationwide
UPC
0324338854037
Lot
Lot # F230169A, Exp. 06/30/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03 recalled?

Yes. FDA published recall D-0323-2024 on February 7, 2024. Reported hazard: Labeling: Label Mix-up

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ZENZEDI. UPC: 0324338854037.